Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 2 (2005), Issue 3 (March)

1. Endobronchial and endoscopic ultrasound-guided real-time fine-needle aspiration for mediastinal staging.
   Eur Respir J, 25(3): 416-21. [Abstract] [Full-text]
2. The accuracy of EUS-FNA in assessing mediastinal lymphadenopathy and staging patients with NSCLC.
   Eur Respir J, 25(3): 410-5. [Abstract] [Full-text]
3. Semiparametric estimation of proportional mean residual life model in presence of censoring.
   Biometrics, 61(1): 170-8. [Abstract] [Full-text]
4. Enhancement of laser cancer treatment by a chitosan-derived immunoadjuvant.
   Photochem Photobiol, 81(1): 190-5. [Abstract] [Full-text]
5. Contribution of hMTH1 to the maintenance of 8-oxoguanine levels in lung DNA of non-small-cell lung cancer patients.
   J Natl Cancer Inst, 97(5): 384-95. [Abstract] [Full-text]
6. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.
   J Natl Cancer Inst, 97(5): 339-46. [Abstract] [Full-text]
7. Effect of lung cancer surgery on quality of life.
   Thorax, 60(3): 234-8. [Abstract] [Full-text]
8. Ultrasound guided cytological aspiration of supraclavicular lymph nodes in patients with suspected lung cancer.
   Thorax, 60(3): 229-33. [Abstract] [Full-text]
9. Fast T1- and T2-weighted pulmonary MR-imaging in patients with bronchial carcinoma.
   Eur J Radiol, 53(3): 478-88. [Abstract] [Full-text]
10. Transcervical extended mediastinal lymphadenectomy--the new operative technique and early results in lung cancer staging.
    Eur J Cardiothorac Surg, 27(3): 384-90; discussion 390. [Abstract] [Full-text]
11. Postresectional pulmonary oxidative stress in lung cancer patients. The role of one-lung ventilation.
    Eur J Cardiothorac Surg, 27(3): 379-82; discussion 382-3. [Abstract] [Full-text]
12. Inability to perform maximal stair climbing test before lung resection: a propensity score analysis on early outcome.
    Eur J Cardiothorac Surg, 27(3): 367-72. [Abstract] [Full-text]
13. Primary lung adenocarcinoma with massive lymphocyte infiltration.
    Am J Clin Pathol, 123(4): 547-52. [Abstract] [Full-text]
14. Multitarget FISH analysis in the diagnosis of lung cancer.
    Am J Clin Pathol, 123(4): 516-23. [Abstract] [Full-text]
15. Cell cycle regulation and its aberrations in human lung carcinoma.
    Pathol Int, 55(3): 95-105. [Abstract] [Full-text]
16. Incidence, age at onset, and potential reasons of malignant transformation in recurrent respiratory papillomatosis patients: 20 years experience.
    Otolaryngol Head Neck Surg, 132(3): 392-4. [Abstract] [Full-text]
17. Surveillance computed tomography after complete resection for non-small cell lung cancer: results and costs.
    J Thorac Cardiovasc Surg, 129(3): 652-60. [Abstract] [Full-text]
18. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates.
    J Thorac Cardiovasc Surg, 129(3): 639-44. [Abstract] [Full-text]
19. Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients.
    Clin Cancer Res, 11(4): 1534-8. [Abstract] [Full-text]
20. Exploring vitamin and mineral supplementation and purported clinical effects in patients with small cell lung cancer: results from the Mayo Clinic lung cancer cohort.
    Nutr Cancer, 51(1): 7-12. [Abstract] [Full-text]
21. Increased plasma levels of urokinase plasminogen activator and matrix metalloproteinase-9 in nonsmall cell lung cancer patients.
    Clin Chim Acta, 354(1): 91-9. [Abstract] [Full-text]
22. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
    J Gene Med, 7(2): 145-57. [Abstract] [Full-text]
23. Changes to levels of serum neuron-specific enolase in a patient with small cell carcinoma of the pancreas.
    J Hepatobiliary Pancreat Surg, 12(1): 93-8. [Abstract] [Full-text]
24. Pulmonary malakoplakia coexistent with tuberculosis of the hilar lymph node mimicking malignancy.
    Respiration, 72(1): 95-100. [Abstract] [Full-text]
25. Role of cdk4, p16INK4, and Rb expression in the prognosis of bronchioloalveolar carcinomas.
    Respiration, 72(1): 68-73. [Abstract] [Full-text]
26. ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis.
    Cancer Res, 65(5): 1858-67. [Abstract] [Full-text]
27. Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer.
    Cancer Res, 65(5): 1778-82. [Abstract] [Full-text]
28. Multidrug transporter ABCG2 prevents tumor cell death induced by the epidermal growth factor receptor inhibitor Iressa (ZD1839, Gefitinib).
    Cancer Res, 65(5): 1770-7. [Abstract] [Full-text]
29. Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: eradication of autologous mouse prostate cancer.
    Cancer Res, 65(5): 1761-9. [Abstract] [Full-text]
30. Overexpression of soluble TRAIL induces apoptosis in human lung adenocarcinoma and inhibits growth of tumor xenografts in nude mice.
    Cancer Res, 65(5): 1687-92. [Abstract] [Full-text]
31. Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.
    Cancer Res, 65(5): 1664-9. [Abstract] [Full-text]
32. Somatic mutations of the HER2 kinase domain in lung adenocarcinomas.
    Cancer Res, 65(5): 1642-6. [Abstract] [Full-text]
33. A phase II study of hyperfractionated accelerated radiotherapy (HART) after induction cisplatin (CDDP) and vinorelbine (VNR) for stage III non-small-cell lung cancer (NSCLC).
    Int J Radiat Oncol Biol Phys, 61(4): 1117-22. [Abstract] [Full-text]
34. Expression of TARSH gene in MEFs senescence and its potential implication in human lung cancer.
    Biochem Biophys Res Commun, 329(3): 1031-8. [Abstract] [Full-text]
35. Atmospheric polycyclic aromatic hydrocarbons: size distribution, estimation of their risk and their depositions to the human respiratory tract.
    Sci Total Environ, 340(1): 71-80. [Abstract] [Full-text]
36. Bilateral intraosseous adenoid cystic carcinoma of the mandible: report of a case with lung metastases at first clinical presentation.
    Oral Dis, 11(2): 109-12. [Abstract] [Full-text]
37. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Cancer, 103(6): 1154-64. [Abstract] [Full-text]
38. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study.
    Cancer, 103(6): 1265-73. [Abstract] [Full-text]
39. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience.
    Cancer, 103(6): 1172-8. [Abstract] [Full-text]
40. Pulmonary capillary haemangiomatosis in children and adolescents: report of a new case and a review of the literature.
    Eur J Pediatr, 163(12): 731-7. [Abstract] [Full-text]
41. Critical presentation of pleuropulmonary blastoma.
    Pediatr Surg Int, 21(3): 223-6. [Abstract] [Full-text]
42. Aberrant methylation of SPARC in human lung cancers.
    Br J Cancer, 92(5): 942-8. [Abstract] [Full-text]
43. Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions.
    Clin Cancer Res, 11(5): 2074-82. [Abstract] [Full-text]
44. Antisense inhibition of methylenetetrahydrofolate reductase reduces cancer cell survival in vitro and tumor growth in vivo.
    Clin Cancer Res, 11(5): 2047-52. [Abstract] [Full-text]
45. A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer.
    Clin Cancer Res, 11(5): 1910-7. [Abstract] [Full-text]
46. Phase II evaluation of docetaxel-modulated capecitabine in previously treated patients with non-small cell lung cancer.
    Clin Cancer Res, 11(5): 1870-6. [Abstract] [Full-text]
47. Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas.
    Clin Cancer Res, 11(5): 1776-85. [Abstract] [Full-text]
48. ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines.
    Proc Natl Acad Sci U S A, 102(10): 3788-93. [Abstract] [Full-text]
49. Pas1c1 is a candidate for the mouse pulmonary adenoma susceptibility 1 locus.
    Oncogene, 24(11): 1958-63. [Abstract] [Full-text]
50. Positron emission tomography and bone metastases.
    Semin Nucl Med, 35(2): 135-42. [Abstract] [Full-text]
51. ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer.
    Chest, 127(3): 978-83. [Abstract] [Full-text]
52. Radiofrequency ablation of pulmonary tumors and normal lung tissue in swine and rabbits.
    Chest, 127(3): 973-7. [Abstract] [Full-text]
53. Surgically curable peripheral lung carcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival.
    Chest, 127(3): 871-8. [Abstract] [Full-text]
54. Lung cancer in women: analysis of the national Surveillance, Epidemiology, and End Results database.
    Chest, 127(3): 768-77. [Abstract] [Full-text]
55. Nonsteroidal antiinflammatory drug use and lung cancer: a metaanalysis.
    Chest, 127(3): 748-54. [Abstract] [Full-text]
56. Significant progress in palliative treatment of non-small cell lung cancer in the past decade.
    Chest, 127(3): 738-47. [Abstract] [Full-text]
57. The chemopreventive effects of orally administered dexamethasone in Strain A/J mice following cessation of smoke exposure.
    Inhal Toxicol, 17(2): 119-22. [Abstract] [Full-text]
58. How to develop a successful cancer drug--molecules to medicines or targets to treatments?
    Eur J Cancer, 41(5): 676-82. [Abstract] [Full-text]
59. Incidental lung cancers identified at coronial autopsy: implications for overdiagnosis of lung cancer by screening.
    Respir Med, 99(4): 501-7. [Abstract] [Full-text]
60. Comparison of two dimensional and three dimensional radiotherapy treatment planning in locally advanced non-small cell lung cancer treated with continuous hyperfractionated accelerated radiotherapy weekend less.
    Radiother Oncol, 74(3): 307-14. [Abstract] [Full-text]
61. Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes.
    Cancer Epidemiol Biomarkers Prev, 14(3): 693-8. [Abstract] [Full-text]
62. Contemporary lung cancer trends among U.S. women.
    Cancer Epidemiol Biomarkers Prev, 14(3): 582-5. [Abstract] [Full-text]
63. Influence of type of cigarette on peripheral versus central lung cancer.
    Cancer Epidemiol Biomarkers Prev, 14(3): 576-81. [Abstract] [Full-text]
64. Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer.
    Cancer Epidemiol Biomarkers Prev, 14(3): 571-5. [Abstract] [Full-text]
65. Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk.
    Cancer Epidemiol Biomarkers Prev, 14(3): 567-70. [Abstract] [Full-text]
66. Cost-effectiveness analysis of strategies introducing FDG-PET into the mediastinal staging of non-small-cell lung cancer from the French healthcare system perspective.
    Clin Radiol, 60(4): 479-92. [Abstract] [Full-text]
67. Evaluation of automated lung nodule detection on low-dose computed tomography scans from a lung cancer screening program(1).
    Acad Radiol, 12(3): 337-46. [Abstract] [Full-text]
68. Radiotherapy for oral cancer as a risk factor for second primary cancers.
    Cancer Lett, 220(2): 185-95. [Abstract] [Full-text]
69. Contaminants of PC-SPES are not responsible for cytotoxicity in human small-cell lung carcinoma cells.
    Cancer Lett, 220(2): 171-5. [Abstract] [Full-text]
70. KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer.
    Biochem Biophys Res Commun, 329(4): 1260-6. [Abstract] [Full-text]
71. p63 immunostaining in destained bronchoscopic cytological specimens.
    Diagn Cytopathol, 32(4): 198-203. [Abstract] [Full-text]
72. Mouse models for human lung cancer.
    Genes Dev, 19(6): 643-64. [Abstract] [Full-text]
73. Clinical-scale high-throughput human plasma proteome analysis: lung adenocarcinoma.
    Proteomics, 5(4): 1150-9. [Abstract] [Full-text]
74. Different techniques for urinary protein analysis of normal and lung cancer patients.
    Proteomics, 5(4): 1140-9. [Abstract] [Full-text]
75. Estimating the growth rates of primary lung tumours from samples with missing measurements.
    Stat Med, 24(7): 1117-34. [Abstract] [Full-text]
76. Levels of depressive symptoms in spouses of people with lung cancer: effects of personality, social support, and caregiving burden.
    Psychosomatics, 46(2): 123-30. [Abstract] [Full-text]
77. EGR1 predicts PTEN and survival in patients with non-small-cell lung cancer.
    J Clin Oncol, 23(9): 1921-6. [Abstract] [Full-text]
78. Re-treatment of a lung tumour using a simple intensity-modulated radiotherapy approach.
    Br J Radiol, 78(928): 358-61. [Abstract] [Full-text]
79. Redesign of thoracic surgical services within a cancer network-using an oncology focus to inform change.
    Eur J Oncol Nurs, 9(1): 74-8. [Abstract] [Full-text]
80. Examining the relationship between lung cancer and radon in small areas across Scotland.
    Health Place, 11(3): 275-82. [Abstract] [Full-text]
81. Management of spontaneous perforation of esophageal cancer with covered self expanding metallic stents.
    Dis Esophagus, 18(1): 67-9. [Abstract] [Full-text]
82. Novel adenoviral vectors coding for GFP-tagged wtCFTR and deltaF508-CFTR: characterization of expression and electrophysiological properties in A549 cells.
    Pflugers Arch, 449(3): 278-87. [Abstract] [Full-text]
83. Changing trends in US mesothelioma incidence.
    Occup Environ Med, 62(4): 270. [Abstract] [Full-text]
84. Chronic toxicity and carcinogenicity of 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin displays a distinct dose/time toxicity threshold (c x t = k) and a life-prolonging subthreshold effect.
    Food Chem Toxicol, 43(5): 729-40. [Abstract] [Full-text]
85. Quantification of free RNA in serum and bronchial lavage: a new diagnostic tool in lung cancer detection?
    Lung Cancer, 48(1): 145-7. [Abstract] [Full-text]
86. Efficacy of the tyrosine kinase inhibitor gefitinib in a patient with metastatic small cell lung cancer.
    Lung Cancer, 48(1): 141-4. [Abstract] [Full-text]
87. Octreotide treatment for paraneoplastic intestinal pseudo-obstruction complicating SCLC.
    Lung Cancer, 48(1): 137-40. [Abstract] [Full-text]
88. Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC.
    Lung Cancer, 48(1): 129-35. [Abstract] [Full-text]
89. Increased dose-intensity of gemcitabine in advanced non small cell lung cancer (NSCLC): a multicenter phase II study in elderly patients from the "polmone toscano group" (POLTO).
    Lung Cancer, 48(1): 121-7. [Abstract] [Full-text]
90. Phase I study of combination chemotherapy with gemcitabine and irinotecan for non-small cell lung cancer.
    Lung Cancer, 48(1): 115-9. [Abstract] [Full-text]
91. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer.
    Lung Cancer, 48(1): 107-14. [Abstract] [Full-text]
92. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature?
    Lung Cancer, 48(1): 93-102. [Abstract] [Full-text]
93. Endoscopic ultrasound guided biopsy versus mediastinoscopy for analysis of paratracheal and subcarinal lymph nodes in lung cancer staging.
    Lung Cancer, 48(1): 85-92. [Abstract] [Full-text]
94. Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction.
    Lung Cancer, 48(1): 77-83. [Abstract] [Full-text]
95. Expression of E-cadherin and nm23 is associated with the clinicopathological factors of human non-small cell lung cancer in China.
    Lung Cancer, 48(1): 69-76. [Abstract] [Full-text]
96. HER2/neu expression and amplification in non-small cell lung cancer prior to and after neoadjuvant therapy.
    Lung Cancer, 48(1): 59-67. [Abstract] [Full-text]
97. Cyclooxygenase-2 protein levels are independent of epidermal growth factor receptor expression or activation in operable non-small cell lung cancer.
    Lung Cancer, 48(1): 47-57. [Abstract] [Full-text]
98. Overexpression of vascular endothelial growth factor and its receptors in bronchial dypslasia demonstrated by quantitative RT-PCR analysis.
    Lung Cancer, 48(1): 31-45. [Abstract] [Full-text]
99. A common polymorphism in the 3'UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population.
    Lung Cancer, 48(1): 11-7. [Abstract] [Full-text]
100. Lung cancer in women.
     Lung Cancer, 48(1): 1-9. [Abstract] [Full-text]
101. New therapeutic approaches for early stage non-small cell lung cancer.
     Surg Oncol, 14(1): 27-32. [Abstract] [Full-text]
102. Effect of natural and synthetic estrogens on a549 lung cancer cells: correlation of chemical structures with cytotoxic effects.
     Chem Res Toxicol, 18(3): 466-74. [Abstract] [Full-text]
103. Genetic changes and clonality relationship between primary colorectal cancers and their pulmonary metastases--an analysis by comparative genomic hybridization.
     Genes Chromosomes Cancer, 43(1): 25-36. [Abstract] [Full-text]
104. Peroxisome proliferator-activated receptor-gamma ligands inhibit alpha5 integrin gene transcription in non-small cell lung carcinoma cells.
     Am J Respir Cell Mol Biol, 32(4): 350-9. [Abstract] [Full-text]
105. Residential radon exposure, diet and lung cancer: a case-control study in a Mediterranean region.
     Int J Cancer, 114(6): 983-91. [Abstract] [Full-text]
106. Use of a transgenic mouse model to identify markers of human lung tumors.
     Int J Cancer, 114(6): 977-82. [Abstract] [Full-text]
107. Effects of basic fibroblast factor (bFGF) on MMP-2, TIMP-2, and type-I collagen levels in human lung carcinoma fibroblasts.
     Biochimie, 87(3): 343-51. [Abstract] [Full-text]
108. An association between a NQO1 genetic polymorphism and risk of lung cancer.
     Mutat Res, 582(1): 71-8. [Abstract] [Full-text]
109. Green tea consumption, genetic susceptibility, PAH-rich smoky coal, and the risk of lung cancer.
     Mutat Res, 582(1): 53-60. [Abstract] [Full-text]
110. Smoking cessation and lung cancer mortality in a cohort of middle-aged Canadian women.
     Ann Epidemiol, 15(4): 302-9. [Abstract] [Full-text]
111. Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin.
     Ann Oncol, 16(4): 602-10. [Abstract] [Full-text]
112. Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells.
     Hum Mol Genet, 14(7): 973-82. [Abstract] [Full-text]
113. Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancer.
     Ann Oncol, 16(4): 597-601. [Abstract] [Full-text]
114. Living-donor lobar lung transplantation for pulmonary and abdominopelvic lymphangioleiomyomatosis.
     Thorac Cardiovasc Surg, 53(2): 125-7. [Abstract] [Full-text]
115. The importance of histology in the evaluation of pulmonary transplantation: carcinomatous lymphangitis.
     Thorac Cardiovasc Surg, 53(2): 122-3. [Abstract] [Full-text]
116. UFT inhibits lung metastases in spontaneous metastasis model of lung cancer.
     Thorac Cardiovasc Surg, 53(2): 118-21. [Abstract] [Full-text]
117. Frequency of loss of heterozygosity at 3 p, 9 p, 13 q, and 17 p is related to proliferative activity in smokers with stage I non-small cell lung cancer.
     Thorac Cardiovasc Surg, 53(2): 114-7. [Abstract] [Full-text]
118. Targeting of Rad51-dependent homologous recombination: implications for the radiation sensitivity of human lung cancer cell lines.
     Br J Cancer, 92(6): 1089-97. [Abstract] [Full-text]
119. Success of a smoking cessation program among smoking relatives of patients with serious smoking-related pulmonary disorders.
     Eur Addict Res, 11(2): 57-61. [Abstract] [Full-text]
120. Prognosis and survival after radical resection of primary adenosquamous lung carcinoma.
     Eur J Cardiothorac Surg, 27(4): 686-92. [Abstract] [Full-text]
121. Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer?
     Eur J Cardiothorac Surg, 27(4): 680-5. [Abstract] [Full-text]
122. A case-matched study of anatomical segmentectomy versus lobectomy for stage I lung cancer in high-risk patients.
     Eur J Cardiothorac Surg, 27(4): 675-9. [Abstract] [Full-text]
123. Wood dust exposure and the association with lung cancer risk.
     Am J Ind Med, 47(4): 349-57. [Abstract] [Full-text]
124. A prospective, randomised study to compare two palliative radiotherapy schedules for non-small-cell lung cancer (NSCLC).
     Br J Cancer, 92(6): 1038-45. [Abstract] [Full-text]
125. Survival following lobectomy vs limited resection for stage I lung cancer: a meta-analysis.
     Br J Cancer, 92(6): 1033-7. [Abstract] [Full-text]
126. Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo.
     Br J Cancer, 92(6): 1084-8. [Abstract] [Full-text]
127. Decreased n-6/n-3 fatty acid ratio reduces the invasive potential of human lung cancer cells by downregulation of cell adhesion/invasion-related genes.
     Carcinogenesis, 26(4): 779-84. [Abstract] [Full-text]
128. Combinations of glutathione S-transferase genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study.
     Carcinogenesis, 26(4): 811-9. [Abstract] [Full-text]
129. Smoking attributable mortality in the community of Madrid: 1992-1998.
     Eur J Public Health, 15(1): 43-50. [Abstract] [Full-text]
130. A selective small molecule c-MET Inhibitor, PHA665752, cooperates with rapamycin.
     Clin Cancer Res, 11(6): 2312-9. [Abstract] [Full-text]
131. Predictors of the response to gefitinib in refractory non-small cell lung cancer.
     Clin Cancer Res, 11(6): 2244-51. [Abstract] [Full-text]
132. Mutations in the tyrosine kinase domain of the epidermal growth factor receptor in non-small cell lung cancer.
     Clin Cancer Res, 11(6): 2106-10. [Abstract] [Full-text]
133. Caspase regulation in non-small cell lung cancer and its potential for therapeutic exploitation.
     Clin Cancer Res, 11(6): 2097-105. [Abstract] [Full-text]
134. Effect of small-sized liposomal Adriamycin administered by various routes on a metastatic breast cancer model.
     Endocr Relat Cancer, 12(1): 93-100. [Abstract] [Full-text]
135. The expression of Bcl-2 family proteins differs between nonsmall cell lung carcinoma subtypes.
     Cancer, 103(7): 1415-9. [Abstract] [Full-text]
136. Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial.
     Eur J Nucl Med Mol Imaging, 32(3): 294-301. [Abstract] [Full-text]
137. Is late diagnosis of lung cancer inevitable? Interview study of patients' recollections of symptoms before diagnosis.
     Thorax, 60(4): 314-9. [Abstract] [Full-text]
138. Segmental pulmonary veno-occlusive disease secondary to lung cancer.
     J Clin Pathol, 58(4): 434-6. [Abstract] [Full-text]
139. Strongyloides stercolaris infection mimicking a malignant tumour in a non-immunocompromised patient. Diagnosis by bronchoalveolar cytology.
     J Clin Pathol, 58(4): 420-2. [Abstract] [Full-text]
140. Primary chordoid meningioma of lung.
     Virchows Arch, 446(3): 333-7. [Abstract] [Full-text]
141. CD10- and CD34-positive periglandular stromal cells in pulmonary benign metastasizing leiomyoma with metaplastic adenomyomatous glands: an ultrastructural and immunohistochemical study.
     Virchows Arch, 446(3): 270-7. [Abstract] [Full-text]
142. Late solitary bone metastasis of a primary pulmonary synovial sarcoma with SYT-SSX1 translocation type: case report with a long follow-up.
     Virchows Arch, 446(3): 310-5. [Abstract] [Full-text]
143. Pilot phase II study of gemcitabine and vinorelbine in patients with recurrent or refractory small cell lung cancer.
     Lung, 183(1): 43-52. [Abstract] [Full-text]
144. Role of serum vascular endothelial growth factor in the prediction of angiogenesis and prognosis for non-small cell lung cancer.
     Lung, 183(1): 29-42. [Abstract] [Full-text]
145. Lysyl oxidase expression in bronchogenic carcinoma.
     Am J Surg, 189(3): 297-301. [Abstract] [Full-text]
146. Transactivation of hsp70-1/2 in geldanamycin-treated human non-small cell lung cancer H460 cells: involvement of intracellular calcium and protein kinase C.
     J Cell Biochem, 94(6): 1199-209. [Abstract] [Full-text]
147. Elevated beta1,4-galactosyltransferase I in highly metastatic human lung cancer cells. Identification of E1AF as important transcription activator.
     J Biol Chem, 280(13): 12503-16. [Abstract] [Full-text]
148. Repressions of MMP-9 expression and NF-kappa B localization are involved in inhibition of lung carcinoma 95-D cell invasion by (-)-epigallocatechin-3-gallate.
     Biomed Pharmacother, 59(3): 98-103. [Abstract] [Full-text]
149. 2-Aminoethoxydiphenyl borate perturbs hormone-sensitive calcium stores and blocks store-operated calcium influx pathways independent of cytoskeletal disruption in human A549 lung cancer cells.
     Biochem Pharmacol, 69(8): 1177-86. [Abstract] [Full-text]
150. Hydrogen peroxide degradation and selective carbidopa-induced cytotoxicity against human tumor lines.
     Biochem Pharmacol, 69(8): 1159-66. [Abstract] [Full-text]
151. Fusion of respiration-correlated PET and CT scans: correlated lung tumour motion in anatomical and functional scans.
     Phys Med Biol, 50(7): 1569-83. [Abstract] [Full-text]
152. A comparison of Monte Carlo dose calculation denoising techniques.
     Phys Med Biol, 50(5): 909-22. [Abstract] [Full-text]
153. The influence of beam model differences in the comparison of dose calculation algorithms for lung cancer treatment planning.
     Phys Med Biol, 50(5): 801-15. [Abstract] [Full-text]
154. Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures.
     Radiology, 235(1): 289-98. [Abstract] [Full-text]
155. Analysis of tumor-host interactions by gene expression profiling of lung adenocarcinoma xenografts identifies genes involved in tumor formation.
     Mol Cancer Res, 3(3): 119-29. [Abstract] [Full-text]
156. Abnormal stability of wild-type p53 protein in a human lung carcinoma cell line.
     Biochem Biophys Res Commun, 330(2): 483-8. [Abstract] [Full-text]
157. Association of polymorphisms in the cyclin D1 and XPD genes and susceptibility to cancers of the upper aero-digestive tract.
     Mol Carcinog, 42(4): 222-8. [Abstract] [Full-text]
158. Peripheral solitary pulmonary nodule: CT findings in patients with pulmonary emphysema.
     Radiology, 235(1): 266-73. [Abstract] [Full-text]
159. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer.
     Radiology, 235(1): 208-15. [Abstract] [Full-text]
160. CT screening for lung cancer: five-year prospective experience.
     Radiology, 235(1): 259-65. [Abstract] [Full-text]
161. Nutrition intervention improves outcomes in patients with cancer cachexia receiving chemotherapy--a pilot study.
     Support Care Cancer, 13(4): 270-4. [Abstract] [Full-text]
162. Genomics of lung cancer may change diagnosis, prognosis and therapy.
     Pathol Oncol Res, 11(1): 5-10. [Abstract] [Full-text]
163. Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01.
     J Clin Oncol, 23(10): 2145-54. [Abstract] [Full-text]
164. PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer.
     Neoplasia, 7(3): 294-301. [Abstract] [Full-text]
165. Integrin alpha v beta 3-targeted imaging of lung cancer.
     Neoplasia, 7(3): 271-9. [Abstract] [Full-text]
166. The value of cytology in the diagnostics of lung cancer.
     APMIS, 113(3): 208-12. [Abstract] [Full-text]
167. Sequential 5-Aza 2'-deoxycytidine/depsipeptide FK228 treatment induces tissue factor pathway inhibitor 2 (TFPI-2) expression in cancer cells.
     Oncogene, 24(14): 2386-97. [Abstract] [Full-text]
168. Occupational X-ray examinations and lung cancer risk.
     Int J Cancer, 115(2): 263-7. [Abstract] [Full-text]
169. Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma.
     Int J Cancer, 115(2): 256-62. [Abstract] [Full-text]
170. Interventional radiology in Carney triad.
     Eur Radiol, 15(4): 833-7. [Abstract] [Full-text]

© 2004-2008 Lung Cancer Research Today. All Rights Reserved.